fh tirzepatide cost could raise costs more than $16 trillion in US Reasons for Discontinuation of Obesity

All statistical tests were performed using a two-sided 5% significance level, with corresponding 95% confidence intervals

Findings of the prespecified analysis of the trial, published in The Lancet, suggest that semaglutide and possibly other glucagon-like peptide-1 receptor agonists (GLP-1Ras) should be reconceptualised as disease-modifying treatments rather than solely medications for glycaemic control or weight loss, the studys authors have suggested

In addition, butyrate also reduced lipid content in brown adipose tissue (BAT) and, to a lesser extent, in the liver and muscle (51)

Comparing them isn't quite apples to oranges, but it's close